The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

Michelle Tarver, of the FDA's Center for Devices and Radiological Health, said: "Today's clearance is an important step for ...

Researchers at the University of California, Irvine, have developed a groundbreaking therapy for Alzheimer’s disease by using stem cells to program human immune cells for targeted treatment.

Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.

Our sense of self is shaped by a small brain region called the precuneus. Now, research suggests that targeting that area may preserve brain function in early-stage Alzheimer's.

Alzheimer’s researcher Donald Weaver tells The Conversation Weekly podcast what he’s learnt during more than 30 years of ...

The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less ...

As researchers work to improve treatment of Alzheimer's disease, new research by UCLA Health identified a candidate drug that ...

And understanding the unique way this disease operates in women’s brains—the role of hormones, how women stay resilient for ...

TREATING cold sores with anti-viral medicines could slash the risk of Alzheimer’s disease by 17 per cent, research suggests. Previous studies have found that the herpes simplex virus – ...

The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...

HSV-1 infection may be linked to the risk for Alzheimer’s disease, but antiviral treatment may be protective, a large ...